Professor Paul Corris

  • Email:
  • Telephone: +44 (0) 191 213 7462
  • Address: Department of Respiratory Medicine
    Freeman Hospital
    High Heaton
    Newcastle upon Tyne
    NE7 7DN

I am part of the Respiratory Medicine Group.

I am a PI in the Institute of Cellular Medicine , Director of the National Pulmonary Hypertension Service (Newcastle) and Deputy Director of the Institute of Transplantation

I am a a distinguished Clinician Scientist  and have been recognised by election to Presidencies of the International Society for Heart and Lung Transplantation and British Thoracic Societies. I am President Elect of the international Pulmonary Vascular Research Institute


Professor of Thoracic Medicine Institute of Cellular Medicine, University of Newcastle upon Tyne

Hon Consultant Physician, Regional Cardiothoracic Centre, Freeman Hospital Newcastle

Director National Pulmonary Vascular Service (Newcastle)

Deputy Director Institute of Transplantation Newcastle University and Newcastle upon Tyne Hospitals NHS Trust

Clinical Respiratory Lead NHS North

Chair National PH CRG

Collaborative Research Lead UK National Pulmonary Hypertension Service

Elected  Staff Governor The Newcastle upon Tyne Hospitals NHS Foundation Trust


1979 Class prize in Surgery (Proxime Accessit)

1984 Medical Research Society Eli-Lily Prize

1986 British Thoracic Society/Fisons Travelling Fellowship

1999 Bradshaw Lecture, Royal College of Physicians London

2000 Visiting Professor University of Western Australia

2004 Supervisor British Thoracic Society/British Lung Foundation Young scientist of the year

2008 Supervisor European Respiratory Society Best young scientist prize

2006-2008 President European Society for Heart and Lung Transplantation

2007-2008 President International Society for Heart and Lung Transplantation

2009-2010 President British Thoracic Society

2007 Key Science Lecture Medical Research Institute University of Barcelona

2008 Honeyman Gillespie Lecture Edinburgh University

2009 Appointed member Faculty of 1000

2010 Senior Fellow Spanish Transplantation Society

2004 2008 2012 Faculty member World (WHO) PAH Meeting

2010 Elected to Fellowship Pulmonary Vascular Reserach Institute

2014 President Elect Pulmonary Vascular Research Institute


I have given state of the art talks at all International Respiratory and Transplant meetings including ATS ERS BTS ESOT ISHLT Transplantation Society every year for 25 years and have been faculty member for short courses and master classes from BTS ERS and ISHLT every year



Member Joint University Trust Research Executive Committee and Faculty Ethics Committee

Member Cardiothoracic Advisory Group UK Transplant

Clinical Advisor National Institute for Clinical Excellence

Medical Advisor Pulmonary Hypertension Association

CRG Chair PH

Associate Editor Journal of Heart and Lung Transplantation Editorial Board Transplantation

National Clinical lead for collaborative studies in pulmonary hnypertension

Director Research Pulmonary hypertension Newcastle

  1. Clinical trials including commercial with strong academic links with Bayer and Actelion. Preferred indusrty clinical triallist with Pfizer. Current clinical projects in hypoxic vasoconstriction in group 1 patients and peripheral muscle function in group 3 patients
  2. Translational studies  using primary human endothelial cells
  3. Genetic studies including whole genome sequencing in iPAH and cohort studies in BMPR2 mutation patients



2014-2015                   Bayer Scientific Research Grant     £99,000

                                    Riociguat in patients with respiratory disease and hypoxia

2013-2018                   BHF ref SP/12/12/29836                    £1,178,425

                                    National cohort study of heritable pulmonary hypertension

                                   Principal Investigator Prof Nick Morell Co Applicant Prof Paul Corris                                     

2013-2018                   MRC ref MR/K020919/1          £3,899,348

                                    Mechanisms underlying the development of pulmonary arterial hypertension

                                   Principal Investigator Prof Nick Morell Co applicant Prof Paul Corris



2012-2015                     McPhail Charitable Trust                  £147,000

                                    Clinical trials in pulmonary hypertension


2011-2015                     MRC ref G1100233                           £314,494  

Developmental Clinical Studies (DCS): Does GM-CSF restore effective neutrophil function in critically ill patients?

Chief investigator Prof John Simpson (Newcastle University). Co-applicant: Prof Paul Corris,


2012-2015                     Newcastle Healthcare Charity Award £111,768

A lipopolysaccharide (LPS) inhalation model to characterise divergent cellular innate immune responses early in the course of acute lung inflammation

Principal Investigator Prof John Simpson. Co-applicant Prof Paul Corris, ref BH110474


2009-2012                     Pfizer Academic Partnership              £120.000

                                    Novel end points in clnical trials of drugs in PAH


2006-2009                     Medical Research Council                    £516,000

                                    Azithromycin in OB    

2007 -2008                    AstraZeneca Academic Partnership      £285,000

                                    Biology of pulmonary vascular endothelial cells in emphysema

2008-2012                     Cystic Fibrosis Trust                            £500,000

                                    In vitro treatment of donor lungs to downregulate inflammation

                                    Co applicant

2008-2012                     Medical Research Council                    £127,000

                                    Endothelial cell biology and emphysema






I am involved in undergraduate teaching of Medical Students throughout the course.

I contribute greatly to postgraduate teaching of medicine within my specialist fields of Pulmonary Hypertension and Lung Transplantation on an International basis via specialist society state of art lecturess and masterclasses.